Welcome to our dedicated page for DGDM news (Ticker: DGDM), a resource for investors and traders seeking the latest updates and insights on DGDM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DGDM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DGDM's position in the market.
Digital Development Partners, Inc., soon to be Black Bird Biotech, Inc. (OTC PINK:DGDM), has partnered with Botanical Research in Motion, Inc. (BRIM) for a comprehensive study on the efficacy of its EPA-certified MiteXstreamTM biopesticide. The initial tests demonstrated significant success in eradicating mite infestations in industrial hemp. MiteXstreamTM is designed for direct application on crops without residual pesticide concerns.
The company is positioned to capitalize on the market with this innovative, eco-friendly solution.
Black Bird Biotech, currently known as Digital Development Partners (OTC PINK:DGDM), aims to qualify its MiteXstream biopesticide as the first-ever product to receive the EPA's 'Design for Environment' (DfE) logo. This initiative highlights MiteXstream's plant-based, food-grade qualities and low cost for users. The product targets pests without causing harm to beneficial insects or groundwater, addressing the challenges of traditional pesticides. DGDM plans to rename itself to Black Bird Biotech in Q2 2021 to align with its business focus.
Black Bird Biotech's MiteXstreamTM has gained sale approval in Colorado and Nevada, with others like Washington, Oregon, and Montana expected soon. This EPA-certified biopesticide targets pest resistance, offering high effectiveness at a low cost, which appeals to farmers, especially in the cannabis industry. The company plans to expand its approval across all 50 states and explore global partnerships.
In Q2 2021, DGDM will rebrand to Black Bird Biotech to align with its operations effectively.
Digital Development Partners, Inc. (OTC PINK:DGDM) has announced its rebranding to Black Bird Biotech, Inc., effective after fulfilling regulatory requirements. The new name aims to enhance recognition of its EPA-registered plant-based biopesticide, MiteXstream, which is noted for its effectiveness against spider mites without being a traditional toxic pesticide. The rebranding also includes a new logo, signaling a strategic shift to improve brand identity and awareness in a competitive market.
Digital Development Partners (DGDM) has engaged Milestone Management Services for a three-month corporate communications and investor awareness program. DGDM continues to advance its MiteXstream™ biopesticide technology, recently approved by the EPA, with sales now authorized in Nevada and pending in several Western states. The legalization of recreational cannabis in New York could enhance sales prospects. DGDM also offers CBD products under its Grizzly Creek Naturals brand, further expanding its market presence.
Digital Development Partners (OTC PINK:DGDM) has received approval from the State of Nevada for the sale of its EPA-certified biopesticide, MiteXstream, targeting cannabis growers facing issues with spider mites, mold, and mildew. This unique biopesticide can be applied right up to the day of harvest without failing state pesticide tests. With applications in four additional Western states pending, DGDM aims to establish itself as a major player in the cannabis industry.
Digital Development Partners (OTC PINK:DGDM) submitted pesticide approval applications for its MiteXstream biopesticide in Colorado, Nevada, Washington, Oregon, and Montana. This EPA-certified product aims to allow growers to treat crops up to harvest day without failing state testing standards. The company plans to expand these applications to California and New Jersey. MiteXstream is positioned as a significant innovation against spider mites and molds, promising economic benefits for growers. The anticipated approval and subsequent sales are expected within 2-4 weeks.
Digital Development Partners (OTC PINK: DGDM) announced that CEO Fabian Deneault and VP Eric Newlan will appear on Rich TV Live today at 1 PM ET. The interview will focus on the company's MiteXstream biopesticide and its CBD distribution strategy. MiteXstream is known for treating spider mites and mold without state testing failures, enhancing its competitive advantage. DGDM aims to position itself as a major player in cannabis innovation due to MiteXstream's effectiveness in field tests with licensed growers.
Digital Development Partners, Inc. (DGDM) announced that board member Jack Jie Qin will spearhead export sales for the plant-based biopesticide MiteXstream in China, Hong Kong, and Taiwan. This strategic move aims to leverage Qin's experience in establishing sales channels, bolstered by his past success with companies generating over $30 million in annual export revenues. MiteXstream, an EPA-certified product, targets spider mites and pests without state testing failures, positioning DGDM as a potential major innovator in the cannabis industry.
Digital Development Partners, Inc. (DGDM) announced an acquisition that significantly enhances its distribution capabilities for Grizzly Creek CBD products. On February 16, 2021, the Company completed an all-cash transaction to acquire infrastructure assets for approximately 200 new locations, bringing the total to around 250 across Western Montana. CEO Fabian G. Deneault highlighted the potential for meaningful revenue generation from their CBD line, anticipating positive impacts starting in Q2 2021. This move positions DGDM to capitalize on a growing market for CBD products and strengthens its foothold in the competitive landscape.
